| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Revenue | $1.87B | +2.1% |
| Cost of Revenue | $795.8M | +3.8% |
| Gross Profit | $1.07B | +0.9% |
| R&D Expense | $25.2M | +19.4% |
| SG&A Expense | $859.1M | +5.0% |
| Operating Income | $213.6M | -13.0% |
| Pre-tax Income | $220.3M | -5.4% |
| Income Tax | $54.9M | -4.0% |
| Net Income | $165.4M |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Accounts Receivable | $141.4M | +17.7% |
| Inventory | $290.6M | -6.3% |
| Current Assets | $660.3M | -20.1% |
| Total Assets | $1.24B | -3.9% |
| Current Liabilities | $334.3M | -11.9% |
| Long-term Debt | $73.8M | -5.4% |
| Total Liabilities | $585.1M | +7.2% |
| Line Item | 2026-01-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $254.7M | -2.5% |
| Capital Expenditures | $42.7M | +2.0% |
| Investing Cash Flow | -$101.8M | +22.5% |
| Financing Cash Flow | -$321.4M | -53.6% |
| Free Cash Flow | $212.1M | -3.4% |
| -5.9% |
| EPS (Basic) | $2.05 | -1.0% |
| EPS (Diluted) | $2.03 | -1.0% |
| Stockholders' Equity |
| $650.3M |
| -12.1% |